Erickson Financial Group, LLC
CIK
1797734
Location
ALLENTOWN, PA
Portfolio Value
Micro
$939,997
Diversification
Highly concentrated
Filing Date
Global Rank
#7,804
/ 8,586
▲ 75
Top Industry
Drug Manufacturers - General
41.9%
3Y Alpha vs SPY
+3.6%
Period ended 3 months ago
Filed Apr 8, 2026 · 2mo
18 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+94.5%
SPY
+78.1%
Annualised alpha
+3.6%
Max drawdown
−21.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
6 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
74.4%
−0.3 pts
Top 5
98.4%
−0.1 pts
Top 10
100.0%
0.0 pts
HHI
5,770
Highly concentrated−52
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 88.1% | $15,657,692 |
| Technology | 5.3% | $939,997 |
| Healthcare | 5.0% | $888,050 |
| Consumer Defensive | 1.6% | $288,880 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SPY | Spdr S&P 500 ETF Trust | −195 | 3,731 | $2,426,418 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
2 positions ·
$939,997 total
· Technology only
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AAPL |
Apple Inc.
Technology
|
Added | 2,414 | $612,649 | 65.18% | |
| NVDA |
Nvidia Corp
Technology
|
Added | 1,877 | $327,348 | 34.82% |